acetylgalactosamine has been researched along with Disease Models, Animal in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 3 (30.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, M; Hao, X; He, L; Liu, R; Wei, H; Yang, J; Ye, X; Zhang, F | 1 |
| Crouch, PJ; Dames, S; Eisermann, M; Grigoriadis, G; Kysenius, K; Ng, GZ; Nualkaew, T; Schaeper, U; Vadolas, J; Vilcassim, S | 1 |
| Blau, N; Calin, GA; Chatterjee, SS; Coarfa, C; Egranov, SD; Feillet, F; Guéant, JL; Gunaratne, PH; Han, L; Hawke, DH; Hsiao, H; Hu, Q; Hung, MC; Jun, Y; Li, C; Li, Y; Li, YC; Liang, K; Liao, L; Lin, C; Muntau, AC; Namour, F; Nguyen, TK; Pan, Y; Putluri, N; Schiff, M; Sutton, VR; Tan, Z; Tsai, KL; Xing, Z; Xu, J; Yang, L; Ye, Y; Zhang, S; Zhang, Y; Zhang, Z | 1 |
| Choi, B; Islam, SMS; Sayeed, HM; Sohn, S | 1 |
| Butler, JS; Chan, A; Charisse, K; Jadhav, V; Maier, MA; Manoharan, M; Nair, JK; Nguyen, T; Qian, K; Racie, T; Rajeev, KG; Sehgal, A; Shulga-Morskaya, S; van Berkel, TJC; Willoughby, JLS; Yucius, K; Zimmermann, TS | 1 |
| Butler, JS; Fishman, S; Fitzgerald, K; Fleming, MD; Hettinger, JL; Liu, K; Racie, T; Schmidt, PJ; Visner, G | 1 |
| Brünggel, K; Damo, M; Diaceri, G; Hirosue, S; Hubbell, JA; Quaglia-Thermes, X; Raczy, MM; Wilson, DS | 1 |
| Mourão, PA; Zancan, P | 1 |
| Barrett, KE | 1 |
| Calef, E; Gitler, C; Mogyoros, M; Rosenberg, I | 1 |
1 review(s) available for acetylgalactosamine and Disease Models, Animal
| Article | Year |
|---|---|
Lethal recognition between Entamoeba histolytica and the host tissues.
Topics: Acetylgalactosamine; Amebiasis; Animals; Cell Survival; Complement Pathway, Alternative; Cricetinae; Disease Models, Animal; Entamoeba histolytica; Entamoebiasis; Host-Parasite Interactions; Humans; Intestinal Mucosa; Ion Channels; Lectins; Liver Abscess, Amebic; Membrane Proteins; Neutrophils; Protozoan Proteins; Virulence | 1985 |
9 other study(ies) available for acetylgalactosamine and Disease Models, Animal
| Article | Year |
|---|---|
Deficiency of O-linked-glycosylation regulates activation of T cells and aggravates Concanavalin A-induced liver injury.
Topics: Acetylgalactosamine; Animals; Apoptosis; Benzyl Compounds; Cell Proliferation; Concanavalin A; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Glycosylation; Hepatitis, Autoimmune; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes; Time Factors | 2020 |
SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.
Topics: Acetylgalactosamine; Animals; beta-Thalassemia; Deferiprone; Disease Models, Animal; Drug Therapy, Combination; Erythropoiesis; Female; Gene Expression Profiling; Hepcidins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Magnesium; Membrane Proteins; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Spleen; Zinc | 2021 |
A noncoding RNA modulator potentiates phenylalanine metabolism in mice.
Topics: Acetylgalactosamine; Animals; Biopterins; Diet; Disease Models, Animal; Female; Hepatocytes; Humans; Liver; Male; Mice; Mice, Knockout; Nucleic Acid Conformation; Phenylalanine; Phenylalanine Hydroxylase; Phenylketonurias; Protein Binding; RNA, Long Noncoding | 2021 |
Role of N-acetyl galactosamine-4-SO
Topics: Acetylgalactosamine; Animals; Behcet Syndrome; Colchicine; Disease Models, Animal; Dose-Response Relationship, Drug; Down-Regulation; Interleukin-17; Lectins, C-Type; Ligands; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Pentoxifylline; Receptors, Cell Surface; Simplexvirus | 2017 |
Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Topics: Acetylgalactosamine; Animals; Asialoglycoprotein Receptor; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Gene Silencing; Hepatocytes; Humans; Liver Cirrhosis; Mice; Mice, Knockout; Protein Subunits; RNA Interference; RNA, Small Interfering | 2018 |
RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of β-thalassemia intermedia.
Topics: Acetylgalactosamine; Anemia; Animals; beta-Thalassemia; Disease Models, Animal; Erythropoiesis; Hepcidins; Iron Overload; Liver; Membrane Proteins; Mice; RNA Interference; Serine Endopeptidases; Splenectomy | 2018 |
Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes.
Topics: Acetylgalactosamine; Acetylglucosamine; Adoptive Transfer; Animals; Antigen Presentation; Autoantigens; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Diabetes Mellitus, Type 1; Disease Models, Animal; Female; Immune Tolerance; Liver; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Mice, SCID; Spleen; T-Lymphocytes | 2019 |
Venous and arterial thrombosis in rat models: dissociation of the antithrombotic effects of glycosaminoglycans.
Topics: Acetylgalactosamine; Animals; Anticoagulants; Blood Coagulation; Carotid Arteries; Chondroitin Sulfates; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fucose; Glucuronic Acid; Hemorrhage; Heparin; Heparin Cofactor II; Male; Rats; Rats, Wistar; Sea Cucumbers; Venous Thrombosis | 2004 |
Mucus and metastasis.
Topics: Acetylgalactosamine; Animals; Colonic Neoplasms; Disease Models, Animal; Humans; In Vitro Techniques; Liver Neoplasms; Mice; Mice, Nude; Mucins | 1992 |